MRNA Non-operating Income/Expense History: $-8.0M (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	−$18M−350.0%	Not reported	Not reported	Not reported
FY25	−$4M+78.9%	$8M+129.6%	$0+100.0%	−$12M+58.6%
FY24	−$19M+60.4%	−$27M−292.9%	−$12M+76.5%	−$29M+25.6%
FY23	−$48M−269.2%	$14M+207.7%	−$51M−628.6%	−$39M−225.0%
FY22	−$13M−30.0%	−$13M−550.0%	−$7M+30.0%	−$12M−71.4%

01—History

Non-operating Income/Expense History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

−$8.0M

YoY changeLargest recent move−383.3%in FY21Latest +90.8%

4 older moves run past ±150% (largest −536.0%); point at, tap or drag across the bars to read one.

02—Ledger

Non-operating Income/Expense, period by period

Period	Value	Change	Source
FY2025	−$8.0M	+90.8%	10-K
FY2024	−$87.0M	+29.8%	10-K
FY2023	−$124.0M	−175.6%	10-K
FY2022	−$45.0M	−55.2%	10-K
FY2021	−$29.0M	−383.3%	10-K
FY2020	−$6.0M	+25.0%	10-K
FY2019	−$8.0M	−536.0%	10-K
FY2018	$1.8M	+197.9%	10-K
FY2017	−$1.9M	+30.8%	10-K
FY2016	−$2.7M	—	10-K

03—Questions

What is Moderna, Inc.'s current non-operating income/expense?

Moderna, Inc. (MRNA) annual non-operating income/expense for 2025 was $-8.0M, a 90.80% increase from 2024. Moderna, Inc. non-operating income/expense for the quarter ending March 31, 2026 was $-18.0M.

What was Moderna, Inc.'s non-operating income/expense in 2024?

Moderna, Inc. annual non-operating income/expense for 2024 was $-87.0M, a 29.84% increase from 2023.

What was Moderna, Inc.'s non-operating income/expense in 2023?

Moderna, Inc. annual non-operating income/expense for 2023 was $-124.0M, a 175.56% decline from 2022.

Company: Moderna, Inc.
Ticker: MRNA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Moderna, Inc. Non-operating Income/Expense 2016-2026 | MRNA

Key Statistics